S100A4/FSP1: A Prognostic Marker and a Promising Target for Antitumor Therapy
International Journal of Molecular Sciences · 25.09.2025 · 26 (19) · 9370
DOI: 10.3390/ijms26199370 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.09.2025. Verfasst von Maria Bogachek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, 1 Olimpiysky Avenue, 354340 Sirius, Russia. Hauptthemen laut MEDLINE: S100 Calcium-Binding Protein A4, Biomarkers, Tumor, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State program of the «Sirius» federal territory, «Scientific and technological development of the «Sirius» Federal Territory», Russian Science Foundation, Russian state-funded project for ICBFM SB RAS.
Abstract (Originalsprache)
Numerous studies over three decades have confirmed the significant role of S100A4/FSP1 in the development of metastasis, the formation of the cellular and inflammatory components of the tumor microenvironment, and the development of fibrosis. S100A4 is a promising biomarker whose detection is associated with predicting overall survival in cancer patients. The action of S100A4 is mediated by extra- and intracellular signaling pathways involving targets currently used in the development of therapeutic agents, including monoclonal antibodies and drugs for targeted protein degradation. This review is devoted to the analysis of publications from the perspective of developing diagnostic predictive platforms and modern targeted antitumor therapy aimed at inhibiting the effects of S100A4, which allows avoiding the development of side effects and effectively modulates the tumor microenvironment to overcome immunosuppression and chemoresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, 1 Olimpiysky Avenue, 354340 Sirius, Russia.
- Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Akad. Lavrentiev Ave. 8, 630090 Novosibirsk, Russia.
ORCID-Profile: Maria Bogachek, David Sergeevichev, Anna Nushtaeva
Förderung
- State program of the «Sirius» federal territory, «Scientific and technological development of the «Sirius» Federal Territory»
- Russian Science Foundation
- Russian state-funded project for ICBFM SB RAS
Zitieren
APA
Bogachek, M., Kazakova, A., Sergeevichev, D., Vladimirov, S., Richter, V., & Nushtaeva, A. (2025). S100A4/FSP1: A Prognostic Marker and a Promising Target for Antitumor Therapy. International Journal of Molecular Sciences, 26(19), 9370. https://doi.org/10.3390/ijms26199370
Vancouver
Bogachek M, Kazakova A, Sergeevichev D, Vladimirov S, Richter V, Nushtaeva A. S100A4/FSP1: A Prognostic Marker and a Promising Target for Antitumor Therapy. International Journal of Molecular Sciences. 2025;26(19):9370. doi:10.3390/ijms26199370
BibTeX
@article{Bogachek2025,
author = {Bogachek, Maria and Kazakova, Alina and Sergeevichev, David and Vladimirov, Sergey and Richter, Vladimir and Nushtaeva, Anna},
title = {S100A4/FSP1: A Prognostic Marker and a Promising Target for Antitumor Therapy},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9370},
doi = {10.3390/ijms26199370}
}
EUVIMED